465 related articles for article (PubMed ID: 7491707)
1. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707
[TBL] [Abstract][Full Text] [Related]
2. Effect of Neoral or cyclosporine on the development of chronic rejection in an aortic allograft rat model.
Little DM; Stoltenberg RL; Hullett DA; Sollinger HW
Transplant Proc; 1996 Apr; 28(2):880-1. PubMed ID: 8623445
[No Abstract] [Full Text] [Related]
3. Inhibition of graft coronary arteriosclerosis after heart transplantation.
Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A
Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833
[TBL] [Abstract][Full Text] [Related]
4. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
Murphy GJ; Bicknell GR; Nicholson ML
Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine inhibits intimal hyperplasia in rat aortic allografts.
Stoltenberg R; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
Transplant Proc; 1994 Oct; 26(5):2569-70. PubMed ID: 7940794
[No Abstract] [Full Text] [Related]
6. Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.
Fujishiro J; Suzuki C; Kudou S; Yasue T; Hakamata Y; Takahashi M; Murakami T; Hashizume K; Kobayashi E
J Heart Lung Transplant; 2006 Jul; 25(7):825-33. PubMed ID: 16818126
[TBL] [Abstract][Full Text] [Related]
7. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
Koskinen PK; Lemström KB; Häyry PJ
Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397
[TBL] [Abstract][Full Text] [Related]
8. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
Huang WH; Yan Y; De Boer B; Bishop GA; House AK
Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
[TBL] [Abstract][Full Text] [Related]
9. Medial cell apoptosis precedes the development of intimal hyperplasia after transient allogeneic exposure in a rat aortic allograft model of chronic rejection.
Hare GM; Lee TD; Jordan JL; Hirsch GM
Transplant Proc; 1999; 31(1-2):1384-5. PubMed ID: 10083612
[No Abstract] [Full Text] [Related]
10. Suppression of acute rejection prevents graft arteriosclerosis after allogeneic aorta transplantation in the rat.
Geerling RA; de Bruin RW; Scheringa M; Bonthuis F; Jeekel J; Ijzermans JN; Marquet RL
Transplantation; 1994 Dec; 58(11):1258-63. PubMed ID: 7992371
[TBL] [Abstract][Full Text] [Related]
11. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.
Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C
J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085
[TBL] [Abstract][Full Text] [Related]
12. Leflunomide prolongs pulmonary allograft and xenograft survival.
Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
[TBL] [Abstract][Full Text] [Related]
13. Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections.
Ouyang J; Xu D; Zhang X; Qi S; Ma A; Jiang W; Chida N; Sudo Y; Tamura K; Daloze P; Chen H
Transplantation; 2005 May; 79(10):1386-92. PubMed ID: 15912108
[TBL] [Abstract][Full Text] [Related]
14. Nutritional immunomodulation enhances cardiac allograft survival in rats treated with donor-specific transfusion and cyclosporine.
Levy AE; Alexander JW
Transplantation; 1995 Oct; 60(8):812-5. PubMed ID: 7482740
[TBL] [Abstract][Full Text] [Related]
15. Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts.
Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeyoshi I; Morishita Y; Kobayashi E
Transpl Immunol; 2004 Nov; 13(3):219-27. PubMed ID: 15381205
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.
Lijkwan MA; Cooke DT; Martens JM; Kown MH; Murata S; Peterson SH; Hoyt EG; Robbins RC
J Heart Lung Transplant; 2005 Apr; 24(4):439-45. PubMed ID: 15797746
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
[TBL] [Abstract][Full Text] [Related]
18. The impact of acute rejection on the development of intimal hyperplasia associated with chronic rejection.
Hullett DA; Geraghty JG; Stoltenberg RL; Sollinger HW
Transplantation; 1996 Dec; 62(12):1842-6. PubMed ID: 8990374
[TBL] [Abstract][Full Text] [Related]
19. LF 08-0299 in the prophylaxis and treatment of chronic rejection in a rat aortic allograft model.
Lácha J; Rossmann P; Lodererová A; Havlíèková J; Vítko S
Transpl Int; 2000; 13 Suppl 1():S565-7. PubMed ID: 11112075
[TBL] [Abstract][Full Text] [Related]
20. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
